Orbimed Advisors - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$19,231,533
-28.8%
4,180,7680.0%0.41%
-16.4%
Q2 2023$27,007,761
-14.3%
4,180,7680.0%0.49%
-21.0%
Q1 2023$31,522,991
-25.6%
4,180,7680.0%0.62%
-23.6%
Q4 2022$42,351,180
+2.4%
4,180,7680.0%0.81%
+5.5%
Q3 2022$41,348,000
-12.4%
4,180,768
-5.6%
0.77%
-10.2%
Q2 2022$47,188,000
+15.8%
4,430,768
+6.0%
0.86%
+29.3%
Q1 2022$40,762,000
-31.8%
4,180,7680.0%0.66%
-14.0%
Q4 2021$59,785,000
-28.6%
4,180,7680.0%0.77%
-16.5%
Q3 2021$83,783,000
-38.8%
4,180,768
-32.8%
0.92%
-33.5%
Q2 2021$136,906,000
-50.8%
6,223,019
-24.1%
1.38%
-46.8%
Q1 2021$278,498,000
-17.6%
8,200,768
-2.4%
2.60%
-12.0%
Q4 2020$338,047,0008,400,7682.96%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DCVC Bio GP, LLC 29,411$313,000100.00%
Founders Fund VII Management, LLC 3,773,530$40,188,00093.02%
Gruss & Co., LLC 363,778$3,874,00026.99%
Founders Fund Growth Management, LLC 407,017$4,334,00012.66%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$44,387,0005.09%
HARVARD MANAGEMENT CO INC 4,105,095$43,719,0005.06%
Intellectus Partners, LLC 1,089,755$11,606,0003.99%
ArchPoint Investors 630,326$6,713,0002.66%
BRANDYWINE MANAGERS, LLC 56,976$607,0001.49%
Orbimed Advisors 4,180,768$44,525,0000.81%
View complete list of ABCELLERA BIOLOGICS INC shareholders